FIELD: organic chemistry; pharmaceuticals.
SUBSTANCE: group of inventions relates to a compound for the treatment of infection caused by the human immunodeficiency virus (HIV). A compound having the following structural formula, or a pharmaceutically acceptable salt thereof is disclosed. Besides, the following is disclosed: a pharmaceutical composition for use in the treatment of HIV infection containing the specified compound, and the use of this compound for the production of a medicinal product for the treatment of HIV infection.
EFFECT: group of inventions provides effective inhibition of human immunodeficiency virus replication.
4 cl, 2 tbl, 148 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | 2020 |
|
RU2804033C2 |
| OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2014 |
|
RU2674983C1 |
| PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| AZADECALINS CONDENSED WITH HETEROARYLKETONES - GLUCOCORTICOID RECEPTOR MODULATORS | 2013 |
|
RU2639867C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2815814C1 |
| AZAINDAZOLE OR DIAZAINDAZOLE DERIVATIVES AS MEDICINE | 2012 |
|
RU2600976C2 |
| (AZA)INDOLE-, BENZOTHIOPHENE- AND BENZOFURAN-3-SULPHONAMIDES | 2017 |
|
RU2767904C2 |
| OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
